TY - JOUR
T1 - Monthly trends and seasonality of hemodialysis treatment and outcomes of newly initiated patients from the national database (NDB) of Japan
AU - Tsunoda, Ryoya
AU - Mitsutake, Naohiro
AU - Ishikawa, Tomoki
AU - Sato, Jumpei
AU - Goda, Kazuo
AU - Nakashima, Naoki
AU - Kitsuregawa, Masaru
AU - Yamagata, Kunihiro
N1 - Funding Information:
This work was supported by a Grant-in-Aid for Research on Advanced Chronic Kidney Disease (REACH-J), Practical Research Project for Renal Diseases from the Japan Agency for Medical Research and Development (AMED) (grant No. JP20ek0310010), and supported in part by a Health Labour Sciences Research Grant (Research on Policy Planning and Evaluation, Ministry of Health, Labour and Welfare, Japan: JPMH201901011B).
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to The Japanese Society of Nephrology.
PY - 2022/7
Y1 - 2022/7
N2 - Background: The numbers of patients treated with hemodialysis (HD) in Japan are currently quantified by manual survey. As this method requires much effort from medical institutions and cannot achieve 100% response, a more practical method is required. We aimed to establish a novel method for determining the static and dynamic numbers of patients treated with HD. Methods: This observational study used the national medical billing database (termed NDB) of Japan, based on the records of the universal healthcare insurance system. Medical billing data registered in the NDB between April 2011 and March 2015 were analyzed. From 130 billion records, we extracted and analyzed records of patients who had undergone HD at least once per month. Patients’ monthly condition was classified as newly initiated HD, chronic HD, or presumed death, using conditional expressions. We also investigated renal outcome and presumed survival in newly initiated HD patients. Results: In the last month of the study period, 274,100 patients were identified as receiving chronic HD, which is estimated as > 95% of the number of these patients identified in the manual survey so far. The monthly data showed clear seasonality in the incidence of transient HD, which increased in winter and decreased in summer. Conclusion: Analysis of a large national database revealed a significant increase in transient HD in winter and decrease in summer. Applied to additional epidemiological exploratory studies or clinical research, this analytical technique would enable collection of the dynamics of almost all HD patients nationwide.
AB - Background: The numbers of patients treated with hemodialysis (HD) in Japan are currently quantified by manual survey. As this method requires much effort from medical institutions and cannot achieve 100% response, a more practical method is required. We aimed to establish a novel method for determining the static and dynamic numbers of patients treated with HD. Methods: This observational study used the national medical billing database (termed NDB) of Japan, based on the records of the universal healthcare insurance system. Medical billing data registered in the NDB between April 2011 and March 2015 were analyzed. From 130 billion records, we extracted and analyzed records of patients who had undergone HD at least once per month. Patients’ monthly condition was classified as newly initiated HD, chronic HD, or presumed death, using conditional expressions. We also investigated renal outcome and presumed survival in newly initiated HD patients. Results: In the last month of the study period, 274,100 patients were identified as receiving chronic HD, which is estimated as > 95% of the number of these patients identified in the manual survey so far. The monthly data showed clear seasonality in the incidence of transient HD, which increased in winter and decreased in summer. Conclusion: Analysis of a large national database revealed a significant increase in transient HD in winter and decrease in summer. Applied to additional epidemiological exploratory studies or clinical research, this analytical technique would enable collection of the dynamics of almost all HD patients nationwide.
UR - http://www.scopus.com/inward/record.url?scp=85125375550&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85125375550&partnerID=8YFLogxK
U2 - 10.1007/s10157-022-02202-3
DO - 10.1007/s10157-022-02202-3
M3 - Article
C2 - 35226215
AN - SCOPUS:85125375550
SN - 1342-1751
VL - 26
SP - 669
EP - 677
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 7
ER -